The prevalence and pantoprozole associated thrombocytopenia in a community hospital

Expert Opinion on Pharmacotherapy

Volumn 8, Issue 13, 2007, Pages 2025-2028

  Dotan, Efrat ^a   Katz, Randi ^a   Bratcher, Jason ^a   Wasserman, Carrie ^a   Liebman, Michelene ^a   Panagopoulos, Georgia ^a   Spaccavento, Colette ^a  

^a Lennox Hill Hospital   (United States)

Author keywords

Pantoprazole; Pantoprazole induced thrombocytopenia; Proton pump inhibitors; Thrombocytopenia

Indexed keywords

PANTOPRAZOLE; PROTON PUMP INHIBITOR; 2 [[(2 PYRIDYL)METHYL]SULFINYL]BENZIMIDAZOLE DERIVATIVE;

ADULT; AGED; ARTICLE; COHORT ANALYSIS; COMMUNITY HOSPITAL; CONTROLLED STUDY; DISEASE ASSOCIATION; DRUG EXPOSURE; DRUG SAFETY; FEMALE; GASTRITIS; GASTROESOPHAGEAL REFLUX; HOSPITAL PATIENT; HUMAN; INCIDENCE; MAJOR CLINICAL STUDY; MALE; MEDICAL LITERATURE; MEDICAL RECORD REVIEW; OUTPATIENT CARE; PEPTIC ULCER; POST HOC ANALYSIS; PRESCRIPTION; PREVALENCE; THROMBOCYTE COUNT; THROMBOCYTOPENIA; TREATMENT DURATION; TREATMENT OUTCOME; ADOLESCENT; CHEMICALLY INDUCED DISORDER; COMPARATIVE STUDY; HOSPITALIZATION; MIDDLE AGED; RETROSPECTIVE STUDY;

2-PYRIDINYLMETHYLSULFINYLBENZIMIDAZOLES; ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; COHORT STUDIES; FEMALE; HOSPITALIZATION; HOSPITALS, COMMUNITY; HUMANS; MALE; MIDDLE AGED; PREVALENCE; RETROSPECTIVE STUDIES; THROMBOCYTOPENIA;

EID: 34548637792     PISSN: 14656566     EISSN: None     Source Type: Journal    
DOI: 10.1517/14656566.8.13.2025     Document Type: Article

References (13)

1. WOLFE M, SACHS G: Acid supression: optimizing therapy for gastroduodenal ulcer healing, gastroesophageal reflux disease, and stress-related erosive syndrome. Gastroenterology (2000) 118:S9-S31.
2. DE VAULT K, CASTELL DO: Updated guidelines for the diagnosis and treatment of gastroesophageal reflux disease. Am. J. Gastroenterol. (1999) 94(6)1434-1441;
3. DE VAULT K, CASTELL DO: Update: Am. J. Gastroenterol. (2005) 100(1):190-200.
4. WATSON TD, STARK JE, VESTA KS: Pantoprazole-induced thrombocytopenia. Ann. Pharmacother. (2006) 40:758-761.
5. TSUTSUMI Y, KANAMORI H, YAMATO H et al.: Randomized study of Helicobacter pylori eradication therapy and proton pump inhibitor monotherapy for idiopathic thrombocytopenic purpura. Ann. Heamatol. (2005) 84:807-811.
6. THOMSON PDR: Physicians Desk Reference, 59th Edition (2005).
7. BECK J: Efficacy of esomeprazole in patients with acid-peptic disorders. Gastroenterol. Nurs. (2004) 27(2):44-49.
8. DIAL S, DELANEY JA, BARKUN AN, SUISSA S: Use of gastric acid-suppressive agents and the risk of community-acquired Clostridium difficile-associated disease. JAMA (2005) 294(23):2989-2995.
9. COLLARD HR, SAINT S, MATTHEY MA: Prevention of ventilator-associated pneumonia: an evidence-based systematic review. Ann. Intern. Med. (2003) 138:494-501.
10. GILLEN D, MCCOLL KE: Problems related to acid rebound and tachyphylaxis. Best Pract. Res. Clin. Gastroenterol. (2001) 15:487-495.
11. WALDUM HL, AMESTA JS, BRENNA E et al.: Marked increase in gastric acid secretory capacity after omeprazole treatment. Gut (1996) 39:649-653.
12. KLINKENBERG-KNOL EC, NELIS F, DENT J et al.: Long-term omeprazole treatment in resistant gastroesophageal reflux disease: efficacy, safety, and influence on gastric mucosa. Gastroenterology (2000) 118 (4):661-669.
13. OHMAN EM, GRANGER CR, RICE L et al.: Identification, diagnosis and treatment of heparin-induced thrombocytopenia and thrombosis: a registry of prolonged heparin use and thrombocytopenia among hospitalized patients with and without cardiovascular disease. The complication after thrombocytopenia caused by heparin (CATCH) registry steering committee. J. Thromb. Thrombolysis (2005) 19(1):9-11.